Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge - 05/04/18
Doi : 10.1016/j.jaci.2017.11.013
John-Paul Oliveria, PhD, Amani I. El-Gammal, MD, Michelle Yee, BSc, Caitlin D. Obminski, BSc, Tara X. Scime, BSc, Richard M. Watson, BSc, Karen Howie, BSc, Paul M. O'Byrne, MB, Roma Sehmi, PhD, Gail M. Gauvreau, PhD 
Department of Medicine, Division of Respirology, McMaster University, Hamilton, Ontario, Canada
| Disclosure of potential conflict of interest: P. M. O'Byrne personally received board membership from Joint Oversight Board for LABA safety study and consultancy fees from AstraZeneca, GSK, Merck, and Boehringer; his institution received grants from AstraZeneca, Amgen, and Genentech for other works. R. Sehmi's institution received grants from GalxoSmithKline, AstraZeneca, Genetech, Sanofi Regeneron, and AllerGen NCE for other works. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 4
P. 1495 - avril 2018 Retour au numéro
Article précédent
- Generation of adult human T-cell progenitors for immunotherapeutic applications
- Laura Simons, Kuiying Ma, Corinne de Chappedelaine, Ranjita Devi Moiranghtem, Elodie Elkaim, Juliette Olivré, Sandrine Susini, Kevin Appourchaux, Christian Reimann, Hanem Sadek, Olivier Pellé, Nicolas Cagnard, Elisa Magrin, Chantal Lagresle-Peyrou, Tom Taghon, Antonio Rausell, Marina Cavazzana, Isabelle André-Schmutz
- Circulating allergen-specific TH2 lymphocytes: CCR4+ rather than CLA+ is the predominant phenotype in peanut-allergic subjects
- Lars H. Blom, Nanna Juel-Berg, Lau Fabricius Larsen, Kirsten S. Hansen, Lars K. Poulsen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?